Related references
Note: Only part of the references are listed.OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention
David R. Maguire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids
Keith M. Olson et al.
PLOS ONE (2019)
DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism
Eric W. Bell et al.
JOURNAL OF CHEMINFORMATICS (2019)
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Tao Che et al.
CELL (2018)
Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption
Marsida Kallupi et al.
ADDICTION BIOLOGY (2018)
Antidepressant-like effects of BU10119, a novel buprenorphine analogue with mixed k/mu receptor antagonist properties, in mice
Abdulrahman Almatroudi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
The role of regulator of G protein signaling 4 in delta-opioid receptor-mediated behaviors
Isaac J. Dripps et al.
PSYCHOPHARMACOLOGY (2017)
Structural Basis for G Protein-Coupled Receptor Activation
Aashish Manglik et al.
BIOCHEMISTRY (2017)
Buprenorphine plus naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study
Walter Ling et al.
ADDICTION (2016)
KAPPA-OPIOID ANTAGONISTS FOR PSYCHIATRIC DISORDERS: FROM BENCH TO CLINICAL TRIALS
William A. Carlezon et al.
DEPRESSION AND ANXIETY (2016)
C7β-Methyl Analogues of the Orvinols: The Discovery of Kappa Opioid Antagonists with Nociceptin/Orphanin FQ Peptide (NOP) Receptor Partial Agonism and Low, or Zero, Efficacy at Mu Opioid Receptors
Juan Pablo Cueva et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice
Abdulrahman Almatroudi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Structural insights into μ-opioid receptor activation
Weijiao Huang et al.
NATURE (2015)
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
Bogna M. Ignatowska-Jankowska et al.
NEUROPSYCHOPHARMACOLOGY (2015)
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor
Rebecca L. Miller et al.
STRUCTURE (2015)
A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm
Sarah F. Cordery et al.
ADDICTION BIOLOGY (2014)
Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats
Devki D. Sukhtankar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Molecular control of δ-opioid receptor signalling
Gustavo Fenalti et al.
NATURE (2014)
Sex differences in cocaine conditioned place preference in C57BL/6J mice
Elisa R. Hilderbrand et al.
NEUROREPORT (2014)
Development of κ Opioid Receptor Antagonists
F. Ivy Carroll et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Differential Control of Opioid Antinociception to Thermal Stimuli in a Knock-In Mouse Expressing Regulator of G-Protein Signaling-Insensitive Gαo Protein
Jennifer T. Lamberts et al.
JOURNAL OF NEUROSCIENCE (2013)
Effects of the kappa opioid receptor antagonist, norbinaltorphimine, on stress and drug-induced reinstatement of nicotine-conditioned place preference in mice
K. J. Jackson et al.
PSYCHOPHARMACOLOGY (2013)
Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians
Chris-Ellyn Johanson et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Structure of the δ-opioid receptor bound to naltrindole
Sebastien Granier et al.
NATURE (2012)
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Aaron A. Thompson et al.
NATURE (2012)
A Combination of Buprenorphine and Naltrexone Blocks Compulsive Cocaine Intake in Rodents Without Producing Dependence
Sunmee Wee et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The Nociceptin/Orphanin FQ Receptor (NOP) as a Target for Drug Abuse Medications
Nurulain T. Zaveri
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
The Therapeutic Potential of kappa-Opioids for Treatment of Pain and Addiction
Charles Chavkin
NEUROPSYCHOPHARMACOLOGY (2011)
Enhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle
Matthew W. Feltenstein et al.
PSYCHOPHARMACOLOGY (2011)
Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration
Robin E. Sperling et al.
PSYCHOPHARMACOLOGY (2010)
Kappa-opioid ligands in the study and treatment of mood disorders
William A. Carlezon et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders
D. J. McCann
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential
David G. Lambert
NATURE REVIEWS DRUG DISCOVERY (2008)
The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine
Paul Marquez et al.
NEUROPHARMACOLOGY (2008)
The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine
P. Marquez et al.
NEUROSCIENCE (2008)
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system
Van A. Redila et al.
PSYCHOPHARMACOLOGY (2008)
Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses
Kazuto Sakoori et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn
A. N. Carey et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Naltrexone and buprenorphine combination in the treatment of opioid dependence
G. Gerra et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Nociceptin/orphanin FQ evokes knee joint pain in rats via a mast cell independent mechanism
JJ McDougall et al.
NEUROSCIENCE LETTERS (2006)
Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning
JP McLaughlin et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference
JR Shoblock et al.
NEUROPHARMACOLOGY (2005)
Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement
RE Sorge et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Influence of the dose and the number of drug-context pairings on the magnitude and the long-lasting retention of cocaine-induced conditioned place preference in C57BL/6J mice
C Brabant et al.
PSYCHOPHARMACOLOGY (2005)
Sex and estrogen influence drug abuse
ME Carroll et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice
K Sakoori et al.
PSYCHOPHARMACOLOGY (2004)
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence
ID Montoya et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
κ opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses
JP McLaughlin et al.
JOURNAL OF NEUROSCIENCE (2003)
Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats
SD Mague et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Autoradiographic localization of I-125[tyr(14)] nociceptin/orphanin FQ binding sites in macaque primate CNS
KE Bridge et al.
NEUROSCIENCE (2003)
Comparison of receptor mechanisms and efficacy requirements for δ-agonist-induced convulsive activity and antinociception in mice
DC Broom et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Unconditioned and conditioned factors contribute to the 'reinstatement' of cocaine place conditioning following extinction in C57BL/6 mice
KK Szumlinski et al.
BEHAVIOURAL BRAIN RESEARCH (2002)
Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference
J Kotlinska et al.
BEHAVIOURAL PHARMACOLOGY (2002)
Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats
K Lutfy et al.
PSYCHOPHARMACOLOGY (2001)
Share Paper
